Leishmaniasis Treatment Market 2027 by Disease Type, Pathological tests, Therapy type | The Insight Partners

Leishmaniasis Treatment Market Forecast to 2027 - Covid-19 Impact and Global Analysis - by Disease Type (Cutaneous Leishmaniasis, Mucosal Leishmaniasis, Visceral Leishmaniasis); Pathological tests (Serological Tests, Parasitological Evaluation, DNA- Based Methods, Immunological Methods, Others); Therapy type (Drug Therapy, Non-Drug Therapy)

Report Code: TIPRE00008181 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Leishmaniasis is caused by infection with Leishmania parasites, which are spread by the bite of infected female sand flies. The clinical spectrum of leishmaniasis ranges from a self-resolving cutaneous ulcer to disease and even to lethal systemic illness.

MARKET DYNAMICS

The leishmaniasis treatment market is anticipated to grow due to pharmaceutical companies and organizations that are likely to adopt new methods and treatments due to continuous research and development in scientific technology to cure this disease. Moreover, the unmet medical need is estimated to present an opportunity for all research and development programs to invest in the global leishmaniasis drugs market.

MARKET SCOPE

The "Leishmaniasis Treatment Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of in leishmaniasis treatment market with detailed market segmentation by disease type, pathological tests, therapy type, end user and geography. The leishmaniasis treatment market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading in leishmaniasis treatment market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The leishmaniasis treatment market is segmented on the basis of disease type, pathological tests, therapy type and end user. Based on disease type the market is segmented as cutaneous leishmaniasis, mucosal leishmaniasis and visceral leishmaniasis. Further on the basis of cutaneous leishmaniasis the market is segmented as diffuse cutaneous leishmaniasis and mucocutaneous leishmaniais. On the basis of pathological tests the market is categorized as serological tests, parasitological evaluation, DNA- based methods, immunological methods and others. On the basis of therapy type the market is categorized as drug therapy and non-drug therapy. Further on the basis of drug therapy the market is segmented into pentavalent antimonial, antifungal and antibiotics. Further on the basis of non-drug therapy the market is segmented as cauterization, surgical excision and cryotherapy.



Get more information on this report :

REGIONAL FRAMEWORK


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the in leishmaniasis treatment market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The leishmaniasis treatment market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting leishmaniasis treatment market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the leishmaniasis treatment market in these regions.




Get more information on this report :

MARKET PLAYERS


The report covers key developments in the in leishmaniasis treatment market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from in leishmaniasis treatment market are anticipated to have lucrative growth opportunities in the future with the rising demand for in leishmaniasis treatment market in the global market. Below mentioned is the list of few companies engaged in the leishmaniasis treatment market.

The report also includes the profiles of key in leishmaniasis treatment market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  AbbVie Inc.
  •  Enzon Pharmaceuticals (Abelcet)
  •  Gilead Life sciences
  •  Gland Pharma Limited
  •  GlaxoSmithKline plc.
  •  Informa plc.
  •  Lifecare Innovations Private Limited
  •  Paladin Labs Inc.,
  •  Sanofi S.A
  •  Sequus Pharmaceuticals Inc.

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Leishmaniasis Treatment Market - By Disease Type
1.3.2 Leishmaniasis Treatment Market - By Pathological tests
1.3.3 Leishmaniasis Treatment Market - By Therapy type
1.3.4 Leishmaniasis Treatment Market - By Region
1.3.4.1 By Country

2. KEY TAKEAWAYS


3. RESEARCH METHODOLOGY


4. LEISHMANIASIS TREATMENT MARKET LANDSCAPE

4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. LEISHMANIASIS TREATMENT MARKET - KEY MARKET DYNAMICS

5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC

6. LEISHMANIASIS TREATMENT MARKET - GLOBAL MARKET ANALYSIS

6.1. LEISHMANIASIS TREATMENT - GLOBAL MARKET OVERVIEW
6.2. LEISHMANIASIS TREATMENT - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. LEISHMANIASIS TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - DISEASE TYPE

7.1. OVERVIEW
7.2. DISEASE TYPE MARKET FORECASTS AND ANALYSIS
7.3. CUTANEOUS LEISHMANIASIS
7.3.1. Overview
7.3.2. Cutaneous Leishmaniasis Market Forecast and Analysis
7.3.3. Diffuse Cutaneous Leishmaniasis Market
7.3.3.1. Overview
7.3.3.2. Diffuse Cutaneous Leishmaniasis Market Forecast and Analysis
7.3.4. Mucocutaneous Leishmaniais Market
7.3.4.1. Overview
7.3.4.2. Mucocutaneous Leishmaniais Market Forecast and Analysis
7.4. MUCOSAL LEISHMANIASIS
7.4.1. Overview
7.4.2. Mucosal Leishmaniasis Market Forecast and Analysis
7.5. VISCERAL LEISHMANIASIS
7.5.1. Overview
7.5.2. Visceral Leishmaniasis Market Forecast and Analysis

8. LEISHMANIASIS TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - PATHOLOGICAL TESTS

8.1. OVERVIEW
8.2. PATHOLOGICAL TESTS MARKET FORECASTS AND ANALYSIS
8.3. SEROLOGICAL TESTS
8.3.1. Overview
8.3.2. Serological Tests Market Forecast and Analysis
8.4. PARASITOLOGICAL EVALUATION
8.4.1. Overview
8.4.2. Parasitological Evaluation Market Forecast and Analysis
8.5. DNA- BASED METHODS
8.5.1. Overview
8.5.2. DNA- Based Methods Market Forecast and Analysis
8.6. IMMUNOLOGICAL METHODS
8.6.1. Overview
8.6.2. Immunological Methods Market Forecast and Analysis
8.7. OTHERS
8.7.1. Overview
8.7.2. Others Market Forecast and Analysis

9. LEISHMANIASIS TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - THERAPY TYPE

9.1. OVERVIEW
9.2. THERAPY TYPE MARKET FORECASTS AND ANALYSIS
9.3. DRUG THERAPY
9.3.1. Overview
9.3.2. Drug Therapy Market Forecast and Analysis
9.3.3. Pentavalent Antimonials Market
9.3.3.1. Overview
9.3.3.2. Pentavalent Antimonials Market Forecast and Analysis
9.3.4. Antifungal Market
9.3.4.1. Overview
9.3.4.2. Antifungal Market Forecast and Analysis
9.3.5. Antibiotics Market
9.3.5.1. Overview
9.3.5.2. Antibiotics Market Forecast and Analysis
9.4. NON-DRUG THERAPY
9.4.1. Overview
9.4.2. Non-Drug Therapy Market Forecast and Analysis
9.4.3. Cauterization Market
9.4.3.1. Overview
9.4.3.2. Cauterization Market Forecast and Analysis
9.4.4. Surgical Excision Market
9.4.4.1. Overview
9.4.4.2. Surgical Excision Market Forecast and Analysis
9.4.5. Cryotherapy Market
9.4.5.1. Overview
9.4.5.2. Cryotherapy Market Forecast and Analysis
10. LEISHMANIASIS TREATMENT MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Leishmaniasis Treatment Market Overview
10.1.2 North America Leishmaniasis Treatment Market Forecasts and Analysis
10.1.3 North America Leishmaniasis Treatment Market Forecasts and Analysis - By Disease Type
10.1.4 North America Leishmaniasis Treatment Market Forecasts and Analysis - By Pathological tests
10.1.5 North America Leishmaniasis Treatment Market Forecasts and Analysis - By Therapy type
10.1.6 North America Leishmaniasis Treatment Market Forecasts and Analysis - By Countries
10.1.6.1 United States Leishmaniasis Treatment Market
10.1.6.1.1 United States Leishmaniasis Treatment Market by Disease Type
10.1.6.1.2 United States Leishmaniasis Treatment Market by Pathological tests
10.1.6.1.3 United States Leishmaniasis Treatment Market by Therapy type
10.1.6.2 Canada Leishmaniasis Treatment Market
10.1.6.2.1 Canada Leishmaniasis Treatment Market by Disease Type
10.1.6.2.2 Canada Leishmaniasis Treatment Market by Pathological tests
10.1.6.2.3 Canada Leishmaniasis Treatment Market by Therapy type
10.1.6.3 Mexico Leishmaniasis Treatment Market
10.1.6.3.1 Mexico Leishmaniasis Treatment Market by Disease Type
10.1.6.3.2 Mexico Leishmaniasis Treatment Market by Pathological tests
10.1.6.3.3 Mexico Leishmaniasis Treatment Market by Therapy type
10.2. EUROPE
10.2.1 Europe Leishmaniasis Treatment Market Overview
10.2.2 Europe Leishmaniasis Treatment Market Forecasts and Analysis
10.2.3 Europe Leishmaniasis Treatment Market Forecasts and Analysis - By Disease Type
10.2.4 Europe Leishmaniasis Treatment Market Forecasts and Analysis - By Pathological tests
10.2.5 Europe Leishmaniasis Treatment Market Forecasts and Analysis - By Therapy type
10.2.6 Europe Leishmaniasis Treatment Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Leishmaniasis Treatment Market
10.2.6.1.1 Germany Leishmaniasis Treatment Market by Disease Type
10.2.6.1.2 Germany Leishmaniasis Treatment Market by Pathological tests
10.2.6.1.3 Germany Leishmaniasis Treatment Market by Therapy type
10.2.6.2 France Leishmaniasis Treatment Market
10.2.6.2.1 France Leishmaniasis Treatment Market by Disease Type
10.2.6.2.2 France Leishmaniasis Treatment Market by Pathological tests
10.2.6.2.3 France Leishmaniasis Treatment Market by Therapy type
10.2.6.3 Italy Leishmaniasis Treatment Market
10.2.6.3.1 Italy Leishmaniasis Treatment Market by Disease Type
10.2.6.3.2 Italy Leishmaniasis Treatment Market by Pathological tests
10.2.6.3.3 Italy Leishmaniasis Treatment Market by Therapy type
10.2.6.4 Spain Leishmaniasis Treatment Market
10.2.6.4.1 Spain Leishmaniasis Treatment Market by Disease Type
10.2.6.4.2 Spain Leishmaniasis Treatment Market by Pathological tests
10.2.6.4.3 Spain Leishmaniasis Treatment Market by Therapy type
10.2.6.5 United Kingdom Leishmaniasis Treatment Market
10.2.6.5.1 United Kingdom Leishmaniasis Treatment Market by Disease Type
10.2.6.5.2 United Kingdom Leishmaniasis Treatment Market by Pathological tests
10.2.6.5.3 United Kingdom Leishmaniasis Treatment Market by Therapy type
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Leishmaniasis Treatment Market Overview
10.3.2 Asia-Pacific Leishmaniasis Treatment Market Forecasts and Analysis
10.3.3 Asia-Pacific Leishmaniasis Treatment Market Forecasts and Analysis - By Disease Type
10.3.4 Asia-Pacific Leishmaniasis Treatment Market Forecasts and Analysis - By Pathological tests
10.3.5 Asia-Pacific Leishmaniasis Treatment Market Forecasts and Analysis - By Therapy type
10.3.6 Asia-Pacific Leishmaniasis Treatment Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Leishmaniasis Treatment Market
10.3.6.1.1 Australia Leishmaniasis Treatment Market by Disease Type
10.3.6.1.2 Australia Leishmaniasis Treatment Market by Pathological tests
10.3.6.1.3 Australia Leishmaniasis Treatment Market by Therapy type
10.3.6.2 China Leishmaniasis Treatment Market
10.3.6.2.1 China Leishmaniasis Treatment Market by Disease Type
10.3.6.2.2 China Leishmaniasis Treatment Market by Pathological tests
10.3.6.2.3 China Leishmaniasis Treatment Market by Therapy type
10.3.6.3 India Leishmaniasis Treatment Market
10.3.6.3.1 India Leishmaniasis Treatment Market by Disease Type
10.3.6.3.2 India Leishmaniasis Treatment Market by Pathological tests
10.3.6.3.3 India Leishmaniasis Treatment Market by Therapy type
10.3.6.4 Japan Leishmaniasis Treatment Market
10.3.6.4.1 Japan Leishmaniasis Treatment Market by Disease Type
10.3.6.4.2 Japan Leishmaniasis Treatment Market by Pathological tests
10.3.6.4.3 Japan Leishmaniasis Treatment Market by Therapy type
10.3.6.5 South Korea Leishmaniasis Treatment Market
10.3.6.5.1 South Korea Leishmaniasis Treatment Market by Disease Type
10.3.6.5.2 South Korea Leishmaniasis Treatment Market by Pathological tests
10.3.6.5.3 South Korea Leishmaniasis Treatment Market by Therapy type
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Leishmaniasis Treatment Market Overview
10.4.2 Middle East and Africa Leishmaniasis Treatment Market Forecasts and Analysis
10.4.3 Middle East and Africa Leishmaniasis Treatment Market Forecasts and Analysis - By Disease Type
10.4.4 Middle East and Africa Leishmaniasis Treatment Market Forecasts and Analysis - By Pathological tests
10.4.5 Middle East and Africa Leishmaniasis Treatment Market Forecasts and Analysis - By Therapy type
10.4.6 Middle East and Africa Leishmaniasis Treatment Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Leishmaniasis Treatment Market
10.4.6.1.1 South Africa Leishmaniasis Treatment Market by Disease Type
10.4.6.1.2 South Africa Leishmaniasis Treatment Market by Pathological tests
10.4.6.1.3 South Africa Leishmaniasis Treatment Market by Therapy type
10.4.6.2 Saudi Arabia Leishmaniasis Treatment Market
10.4.6.2.1 Saudi Arabia Leishmaniasis Treatment Market by Disease Type
10.4.6.2.2 Saudi Arabia Leishmaniasis Treatment Market by Pathological tests
10.4.6.2.3 Saudi Arabia Leishmaniasis Treatment Market by Therapy type
10.4.6.3 U.A.E Leishmaniasis Treatment Market
10.4.6.3.1 U.A.E Leishmaniasis Treatment Market by Disease Type
10.4.6.3.2 U.A.E Leishmaniasis Treatment Market by Pathological tests
10.4.6.3.3 U.A.E Leishmaniasis Treatment Market by Therapy type
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Leishmaniasis Treatment Market Overview
10.5.2 South and Central America Leishmaniasis Treatment Market Forecasts and Analysis
10.5.3 South and Central America Leishmaniasis Treatment Market Forecasts and Analysis - By Disease Type
10.5.4 South and Central America Leishmaniasis Treatment Market Forecasts and Analysis - By Pathological tests
10.5.5 South and Central America Leishmaniasis Treatment Market Forecasts and Analysis - By Therapy type
10.5.6 South and Central America Leishmaniasis Treatment Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Leishmaniasis Treatment Market
10.5.6.1.1 Brazil Leishmaniasis Treatment Market by Disease Type
10.5.6.1.2 Brazil Leishmaniasis Treatment Market by Pathological tests
10.5.6.1.3 Brazil Leishmaniasis Treatment Market by Therapy type
10.5.6.2 Argentina Leishmaniasis Treatment Market
10.5.6.2.1 Argentina Leishmaniasis Treatment Market by Disease Type
10.5.6.2.2 Argentina Leishmaniasis Treatment Market by Pathological tests
10.5.6.2.3 Argentina Leishmaniasis Treatment Market by Therapy type

11. INDUSTRY LANDSCAPE

11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

12. LEISHMANIASIS TREATMENT MARKET, KEY COMPANY PROFILES

12.1. ABBVIE INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. ENZON PHARMACEUTICALS (ABELCET)
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. GILEAD LIFE SCIENCES
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. GLAND PHARMA LIMITED
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. GLAXOSMITHKLINE PLC.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. INFORMA PLC.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. LIFECARE INNOVATIONS PRIVATE LIMITED
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. PALADIN LABS INC.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. SANOFI S.A
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. SEQUUS PHARMACEUTICALS INC.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments

13. APPENDIX

13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. AbbVie Inc.
2. Enzon Pharmaceuticals (Abelcet)
3. Gilead Life sciences
4. Gland Pharma Limited
5. GlaxoSmithKline plc.
6. Informa plc.
7. Lifecare Innovations Private Limited
8. Paladin Labs Inc.,
9. Sanofi S.A
10. Sequus Pharmaceuticals Inc.
TIPRE00008181
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking